Drug-induced valvular heart disease
- 8 August 2012
- Vol. 99 (1), 7-12
- https://doi.org/10.1136/heartjnl-2012-302239
Abstract
Drug-induced valvular heart disease (DIVHD) was first described in the 1960s. Initially, associations with ergot derivatives used for migraine prevention, or with anorectic drugs, were described. Drugs used for the treatment of Parkinson’s disease and endocrine diseases, like hyperprolactinemia, may also induce VHD. More recently, the use of 3,4-methylendioxymetamphetamine (MDMA, ‘Ecstasy’) and benfluorexhave been found to be associated with DIVHD. Although some of these drugs were withdrawn from the market, several cases of patients requiring valve surgery even years after the cessation of therapy have been reported. DIVHD is not infrequent, may be severe, and has been described in association with several drugs. Even after drug cessation, long-term implications of this type of VHD may persist. The present review underlines the need for a careful evaluation of the associated clinical and echocardiographic risk factors to allow early recognition so as not to delay appropriate management.Keywords
This publication has 33 references indexed in Scilit:
- Serotonin receptors and heart valve disease—It was meant 2BPharmacology & Therapeutics, 2011
- Cardiac valve disease and low-dose dopamine agonist therapy: an artefact of reporting bias?Clinical Endocrinology, 2011
- Drug-induced Valvulopathy: An UpdateToxicologic Pathology, 2010
- Parallel Functional Activity Profiling Reveals Valvulopathogens Are Potent 5-Hydroxytryptamine2BReceptor Agonists: Implications for Drug Safety AssessmentMolecular Pharmacology, 2009
- Cyproheptadine prevents pergolide-induced valvulopathy in rats: an echocardiographic and histopathological studyAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individualsBMC Medicine, 2008
- How to manage ischaemic mitral regurgitationHeart, 2008
- Meta-analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonistsMovement Disorders, 2007
- Drugs and Valvular Heart DiseaseThe New England Journal of Medicine, 2007
- Valvular Heart Disease Associated with Fenfluramine–PhentermineThe New England Journal of Medicine, 1997